compound pharmacy glp 1 Harmony No platform charges Managing Compounded GLP-1 Medications: A

By excreting approximately 70g of glucose per day through urine (~280 kcal/day), Farxiga/Forxiga produces a modest but consistent weight loss of 23 kg on average over 24 weeks in clinical trials

Preclinical studies have evaluated the therapeutic potential of GLP-1 based polypharmacology for the treatment of obesity and diabetes

Weight loss effects vary by indication: in adults with obesity without diabetes, weight loss of up to 21% has been observed at 72 weeks on the 15 mg dose, while patients with type 2 diabetes typically experience 5-12% weight loss

Randomized clinical trials would be needed to prove that GLP-1s could slow cancer progression

Weight Measurement Alert Thresholds and Clinical Responses The following breaks down the different types of safety monitoring alerts and treatment optimization alerts that help inform care and support decisions

The economic burden of obesity-related healthcare costs is staggering, emphasizing the urgent need for effective interventions